...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: New presentations
Reply New Message
Back To Forum List View
Response & what I will attempt...
3
fuzzyjr
Aug 12, 2020 03:27PM
Re: Response & what I will attempt...
1
RVXoldtimer
Aug 14, 2020 11:26AM
Re: Response & what I will attempt...
2
narmac
Aug 15, 2020 08:47AM
Re: Response & what I will attempt...
3
KOO-KOO2
Aug 15, 2020 02:02PM
Re: Response & what I will attempt...
3
RVXoldtimer
Aug 15, 2020 03:03PM
Re: Response & what I will attempt...
1
narmac
Aug 15, 2020 07:09PM
Re: Response & what I will attempt...

Albertaclipper
Aug 16, 2020 10:35AM
Re: Response & what I will attempt...
1
KOO-KOO2
Aug 17, 2020 11:36AM
New presentations
1
Telepanel
Aug 17, 2020 01:19PM

If you are you referring to RVX's  ORI Star Fund D. Debenture, it has been extended by one year from September 26, 2020, to September 26, 2021.

 

Koo

Re: Response & what I will attempt...
1
KayakerBC
Aug 17, 2020 02:13PM
Re: Response & what I will attempt...

Telepanel
Aug 17, 2020 02:22PM
Re: Response & what I will attempt...
1
KOO-KOO2
Aug 17, 2020 02:38PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply